Mindfulness to Mitigate the Effect of Anxiety-depression-fear in Chronic Obstructive Pulmonary Disease (COPD)

Withdrawn before enrolling · Not applicable

Conditions studied: Chronic Obstructive Pulmonary Disease

In brief

People with COPD have a greater risk for symptoms of depression, anxiety, and fear of breathlessness. Those emotions are independently associated with lower physical activity, poorer quality of life, and higher hospitalization and exacerbations; all independent predictors of survival and costs. There is a lack of treatment options to be routinely used in primary clinics for patients with COPD. Systematic reviews suggest that interventions that promote an accepting mode of response, such as mindfulness, might be more appropriate and effective for managing psychological distress in COPD patients, especially breathing-related anxiety. Hypothesis: A home-based 8-week Mindfulness-Based Stress Reduction (MBSR) for COPD targeted to individuals with symptoms of depression, anxiety, or fear of breathlessness delivered by a mindfulness coach using a combination of in-person sessions and remote video call sessions will be effective in improving emotional and overall quality of life, and measured physical activity.

Key facts

Study ID

NCT03385317

Run by

Mayo Clinic

People needed

0

Starts

2016-04-01

Expected to finish

2017-10-31

Last updated by the study team

2017-12-28

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Lung disease diagnosis
• Demonstrated competence in proposed technology
• Current or past smoking status
• Patient Health Questionnaire-2 (PHQ-2) or Generalized Anxiety Disorder scale (GAD-2) score >2 points or answering yes to a validated question of fear of being breathless ("Do you experience fear, or panic when you have difficulty getting your breath a good bit of the time?")

You may not qualify if…

• High likelihood of non-compliance or low confidence using the technology
• Patients currently in pulmonary rehabilitation
• Inability to walk
• Prescribed antidepressant or antianxiety medication within last month
• Documented substance abuse
• Cognitive impairment as defined by the Mini-Mental test score < 24.

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.